(EFX) Equifax - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2944291051

Data, Analytics, Credit, Verification,

EFX EPS (Earnings per Share)

EPS (Earnings per Share) of EFX over the last years for every Quarter: "2020-09-30": 1.87, "2020-12-31": 2, "2021-03-31": 1.97, "2021-06-30": 1.98, "2021-09-30": 1.85, "2021-12-31": 1.84, "2022-03-31": 2.22, "2022-06-30": 2.09, "2022-09-30": 1.73, "2022-12-31": 1.52, "2023-03-31": 1.43, "2023-06-30": 1.71, "2023-09-30": 1.76, "2023-12-31": 1.81, "2024-03-31": 1.5, "2024-06-30": 1.82, "2024-09-30": 1.85, "2024-12-31": 2.12, "2025-03-31": 1.53, "2025-06-30": 2,

EFX Revenue

Revenue of EFX over the last years for every Quarter: 2020-09-30: 1068.3, 2020-12-31: 1118.4, 2021-03-31: 1213, 2021-06-30: 1234.8, 2021-09-30: 1222.9, 2021-12-31: 1253.2, 2022-03-31: 1363.2, 2022-06-30: 1316.7, 2022-09-30: 1244.3, 2022-12-31: 1197.9, 2023-03-31: 1302, 2023-06-30: 1317.6, 2023-09-30: 1319.1, 2023-12-31: 1326.5, 2024-03-31: 1389.4, 2024-06-30: 1430.5, 2024-09-30: 1441.8, 2024-12-31: 1419.4, 2025-03-31: 1442, 2025-06-30: 1537,

Description: EFX Equifax

Equifax Inc (NYSE:EFX) is a leading data, analytics, and technology company that operates through three main segments: Workforce Solutions, U.S. Information Solutions, and International. The company provides a range of services, including employment verification, credit reporting, and identity verification, to businesses, governments, and consumers across multiple countries.

From a business perspective, Equifaxs revenue streams are diversified across its three segments, with a significant presence in the US and international markets. The companys Workforce Solutions segment is a key player in the employment verification market, while its U.S. Information Solutions segment is a major provider of credit information and credit scoring services. The International segment offers a range of information services, including credit reporting and debt collections.

In terms of key performance indicators (KPIs), Equifaxs revenue growth, operating margins, and return on equity (RoE) are important metrics to track. With a RoE of 12.64%, the company demonstrates a reasonable return on shareholder equity. Additionally, the companys debt-to-equity ratio and interest coverage ratio are also important metrics to monitor, as they indicate the companys leverage and ability to service its debt. Furthermore, metrics such as revenue per user, customer acquisition costs, and customer retention rates can provide insights into the companys operational efficiency and competitiveness.

From a valuation perspective, Equifaxs price-to-earnings (P/E) ratio of 53.19 and forward P/E ratio of 34.25 suggest that the stock may be trading at a premium to its earnings. However, the companys market capitalization of $32.37 billion and its position as a market leader in the data and analytics industry may justify a premium valuation. Investors should consider the companys growth prospects, industry trends, and competitive landscape when evaluating the stocks valuation.

EFX Stock Overview

Market Cap in USD 30,251m
Sub-Industry Research & Consulting Services
IPO / Inception 1971-05-11

EFX Stock Ratings

Growth Rating 18.6%
Fundamental 67.2%
Dividend Rating 38.5%
Return 12m vs S&P 500 -25.2%
Analyst Rating 4.17 of 5

EFX Dividends

Dividend Yield 12m 0.68%
Yield on Cost 5y 1.19%
Annual Growth 5y 0.00%
Payout Consistency 92.1%
Payout Ratio 23.7%

EFX Growth Ratios

Growth Correlation 3m -37.5%
Growth Correlation 12m -44.5%
Growth Correlation 5y 51.6%
CAGR 5y 15.03%
CAGR/Max DD 3y 0.46
CAGR/Mean DD 3y 1.25
Sharpe Ratio 12m -0.32
Alpha 0.00
Beta 0.985
Volatility 31.12%
Current Volume 1686.2k
Average Volume 20d 892.8k
Stop Loss 254.4 (-3%)
Signal 0.57

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (639.7m TTM) > 0 and > 6% of Revenue (6% = 350.4m TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA 2.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -7.60% (prev -6.76%; Δ -0.84pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 1.39b > Net Income 639.7m (YES >=105%, WARN >=100%)
Net Debt (4.71b) to EBITDA (1.79b) ratio: 2.64 <= 3.0 (WARN <= 3.5)
Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (125.0m) change vs 12m ago 0.16% (target <= -2.0% for YES)
Gross Margin 55.80% (prev 55.62%; Δ 0.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 48.53% (prev 44.98%; Δ 3.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 4.97 (EBITDA TTM 1.79b / Interest Expense TTM 218.0m) >= 6 (WARN >= 3)

Altman Z'' 2.99

(A) -0.04 = (Total Current Assets 1.50b - Total Current Liabilities 1.95b) / Total Assets 11.92b
(B) 0.52 = Retained Earnings (Balance) 6.23b / Total Assets 11.92b
(C) 0.09 = EBIT TTM 1.08b / Avg Total Assets 12.04b
(D) 0.88 = Book Value of Equity 5.91b / Total Liabilities 6.68b
Total Rating: 2.99 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 67.20

1. Piotroski 6.0pt = 1.0
2. FCF Yield 2.62% = 1.31
3. FCF Margin 15.70% = 3.93
4. Debt/Equity 0.96 = 2.06
5. Debt/Ebitda 2.74 = -1.37
6. ROIC - WACC (= -0.31)% = -0.39
7. RoE 12.93% = 1.08
8. Rev. Trend 95.06% = 7.13
9. EPS Trend 49.31% = 2.47

What is the price of EFX shares?

As of September 18, 2025, the stock is trading at USD 262.33 with a total of 1,686,178 shares traded.
Over the past week, the price has changed by +6.83%, over one month by +7.03%, over three months by +2.69% and over the past year by -11.28%.

Is Equifax a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Equifax (NYSE:EFX) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 67.20 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EFX is around 249.24 USD . This means that EFX is currently overvalued and has a potential downside of -4.99%.

Is EFX a buy, sell or hold?

Equifax has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy EFX.
  • Strong Buy: 11
  • Buy: 5
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the EFX price?

Issuer Target Up/Down from current
Wallstreet Target Price 280.5 6.9%
Analysts Target Price 280.5 6.9%
ValueRay Target Price 277.7 5.8%

Last update: 2025-09-12 04:35

EFX Fundamental Data Overview

Market Cap USD = 30.25b (30.25b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 189.0m USD (last quarter)
P/E Trailing = 47.8655
P/E Forward = 27.027
P/S = 5.1798
P/B = 5.9275
P/EG = 1.1019
Beta = 1.675
Revenue TTM = 5.84b USD
EBIT TTM = 1.08b USD
EBITDA TTM = 1.79b USD
Long Term Debt = 4.05b USD (from longTermDebt, last quarter)
Short Term Debt = 847.0m USD (from shortTermDebt, last quarter)
Debt = 4.90b USD (Calculated: Short Term 847.0m + Long Term 4.05b)
Net Debt = 4.71b USD (from netDebt column, last quarter)
Enterprise Value = 34.96b USD (30.25b + Debt 4.90b - CCE 189.0m)
Interest Coverage Ratio = 4.97 (Ebit TTM 1.08b / Interest Expense TTM 218.0m)
FCF Yield = 2.62% (FCF TTM 917.0m / Enterprise Value 34.96b)
FCF Margin = 15.70% (FCF TTM 917.0m / Revenue TTM 5.84b)
Net Margin = 10.95% (Net Income TTM 639.7m / Revenue TTM 5.84b)
Gross Margin = 55.80% ((Revenue TTM 5.84b - Cost of Revenue TTM 2.58b) / Revenue TTM)
Tobins Q-Ratio = 5.92 (Enterprise Value 34.96b / Book Value Of Equity 5.91b)
Interest Expense / Debt = 1.08% (Interest Expense 53.1m / Debt 4.90b)
Taxrate = 25.07% (203.2m / 810.5m)
NOPAT = 812.3m (EBIT 1.08b * (1 - 25.07%))
Current Ratio = 0.77 (Total Current Assets 1.50b / Total Current Liabilities 1.95b)
Debt / Equity = 0.96 (Debt 4.90b / last Quarter total Stockholder Equity 5.10b)
Debt / EBITDA = 2.74 (Net Debt 4.71b / EBITDA 1.79b)
Debt / FCF = 5.34 (Debt 4.90b / FCF TTM 917.0m)
Total Stockholder Equity = 4.95b (last 4 quarters mean)
RoA = 5.37% (Net Income 639.7m, Total Assets 11.92b )
RoE = 12.93% (Net Income TTM 639.7m / Total Stockholder Equity 4.95b)
RoCE = 12.05% (Ebit 1.08b / (Equity 4.95b + L.T.Debt 4.05b))
RoIC = 8.10% (NOPAT 812.3m / Invested Capital 10.03b)
WACC = 8.41% (E(30.25b)/V(35.15b) * Re(9.64%)) + (D(4.90b)/V(35.15b) * Rd(1.08%) * (1-Tc(0.25)))
Shares Correlation 3-Years: 82.19 | Cagr: 0.12%
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 76.43% ; FCFE base≈820.4m ; Y1≈1.01b ; Y5≈1.73b
Fair Price DCF = 179.5 (DCF Value 22.12b / Shares Outstanding 123.2m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 49.31 | EPS CAGR: 5.42% | SUE: 2.16 | # QB: 2
Revenue Correlation: 95.06 | Revenue CAGR: 7.98% | SUE: N/A | # QB: None

Additional Sources for EFX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle